Testolactone
Testolactone is a synthetic antineoplastic agent that is structurally distinct from the androgen steroid nucleus in possessing a six-membered lactone ring in place of the usual five-membered carbocyclic D-ring. Despite some similarity to testosterone, testolactone has no in vivo androgenic effect.
Anti Estrogen Steroids Testolactone Teslac Treat Breast Cancer Drug
Description:
English name: testolactone
English Name: -TESTOLACTONE; 1,2- dehydrotestololactone; 1,2-didehydro-testololacton; ; 1-dehydrotestololactone;
CAS: 968-93-4
EINECS Number: 213-534-6
Formula: C19H24O3
MW: 300.3921
Molecular Structure:
Density: 1.176g / cm3
Boiling point: 482.02 ° C at 760 mmHg
Flash Point: 213.397 ° C
Vapor Pressure: 0mmHg at 25 ° C
Assay:99%
Appearance:White crystalline powder
Description:
Testolactone is a synthetic antineoplastic agent that is structurally distinct from the androgen steroid nucleus in possessing a six-membered lactone ring in place of the usual five-membered carbocyclic D-ring. Despite some similarity to testosterone, testolactone has no in vivo androgenic effect.
Applications:
Testolactone is approved by the United States Food and Drug Administration (FDA), and its cost usually is covered by insurance. It is classified as an antineoplastic agent, which means that it stops or slows the growth of malignant cells. One advantage of testolactone is that, although it is related to testosterone, it does not cause women to develop male characteristics such as a deep voice or facial hair.
Testolactone is related to the male hormone testosterone. The way in which it inhibits the growth of breast cancer cells is not clear. However, it is known that the hormone estrogen stimulates the growth of some breast cancer cells, and testolactone seems to interfere with estrogen production. The resulting reduction in estrogen levels may slow the growth of breast cancers sensitive to this hormone.
In breast cancer, testolactone is a palliative treatment. This means that it helps relieve symptoms, but does not cure the cancer. It is effective only in about 15% of the women who take it. In these women, however, it helps reduce the size of half or more tumors. Normally testolactone is used along with other chemotherapy drugs for fighting advanced breast cancer.
Testolactone comes as a 50 mg tablet. The dose will depend on the patient’s body weight and her general health, as well as other drugs she may be taking. However, a standard dose is 250 mg (5 tablets) four times a day for three months. It takes at least several weeks before the drug begins to be effective. Tablets should be stored at room temperature.
Contact Now
Contact Now
Testolactone
Testolactone is a synthetic antineoplastic agent that is structurally distinct from the androgen steroid nucleus in possessing a six-membered lactone ring in place of the usual five-membered carbocyclic D-ring. Despite some similarity to testosterone, testolactone has no in vivo androgenic effect.
Raloxifene Hydrochloride
Raloxifene is used to prevent and treat osteoporosis (condition in which the bones become thin and weak and break easily) in women who have undergone menopause (change of life; end of menstrual periods).
DL-Aminoglutethimide
Aminoglutethimide is an adrenal steroid inhibitor. It works by blocking the production of a variety of hormones, including glucocorticoids, mineralocorticoids, estrogens, and androgens and is clinically used in the Treating Cushing syndrome and metastatic breast cancer. Aminoglutethimide is also used by body builders.
Formestane
Formestane is a synthetic steroidal substance with antineoplastic activity. Formestane binds irreversibly to and inhibits the enzyme aromatase, thereby blocking the conversion of cholesterol to pregnenolone and the peripheral aromatization of androgenic precursors into estrogens.
Mesterolone
Mesterolone is an orally applicable androgen, and DHT derivative,is sold under the brand proviron, In the late 70's and early 80'sMestero lone was used with some success in controlled studies ofmen suffering from various forms of depression.
Letrazole (Femara / Formestane)
emara (letrozole) is a type II (non-steroidal) third generation aromatase inhibitor.
Anastrozole (Arimidex)
Anastrozole is also called Arimidex. It is a type of hormone therapy called an aromatase inhibitor. Anastrozoles treats breast cancer in women who have had their menopause.
Exemestane (Aromasin)
Exemestane is indicated for the adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to it for completion of a total of five consecutive years of adjuvant hormonal therapy.
Clomiphene Citrate (Clomid)
Clomifene or clomiphene (trademarked as Androxal, Clomid and Omifin, citrate salt Serophene) is a selective estrogen receptor modulator (SERM) that has become the most widely prescribed drug for ovulation induction to reverse anovulation or oligoovulation.
Tamoxifen Citrate (Nolvadex)
Nolvadex (tamoxifen citrate) is very comparable to Clomid, behaves in the same manner in all tissues, and is a mixed estrogen agonist/antagonist of the same type as Clomid.